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Sirtuin enzymes depend on NAD+ to catalyze protein
deacetylation. Therefore, the lowering of NAD+ during
aging leads to decreased sirtuin activity and may
speed up aging processes in laboratory animals and
humans. In this study, we used a genetic screen to
identify twomutations in the catalytic domain of yeast
Sir2 that allow the enzyme to function in an NAD+-
depleted environment. These mutant enzymes give
rise to a significant increase of yeast replicative life-
span and increase deacetylation by the Sir2 ortho-
log, SIRT1, in mammalian cells. Our data suggest
that these mutations increase the stability of the
conservedcatalyticsirtuindomain, thereby increasing
the catalytic efficiency of the mutant enzymes. Our
approach to identifying sirtuin mutants that permit
function in NAD+-limited environments may inform
the design of smallmolecules that canmaintain sirtuin
activity in aging organisms.INTRODUCTION
Originally discovered for its role in yeast genomic silencing, Sir2
is a nicotinamide adenine dinucleotide (NAD+)-dependent
deacetylase that mediates gene silencing and aging (Imai
et al., 2000). Sir2-related proteins, or sirtuins—especially the
mammalian Sir2 isoform SIRT1—have been shown to modulate
numerous diseases in mouse models, including metabolic disor-
ders, neurodegeneration, cardiovascular disease, cancers, and
aging (Imai and Guarente, 2014; Guarente, 2013).
Acetylation of specific lysine (Lys) residues in the amino ter-
minus of histone proteins is recognized as a fundamental
epigenetic mark that affects transcriptional regulation (Roth-
bart and Strahl, 2014). Histone acetylation is generally associ-
ated with transcriptional activation, as Lys residues in histone
proteins neutralize negative charges along the DNA backbone.
Deacetylation, therefore, results in chromatin condensation,
which is associated with transcriptional repression and gene
silencing. Post-translational modifications, including deacety-
lation, also recruit regulatory molecules to chromatin and2310 Cell Reports 18, 2310–2319, March 7, 2017 ª 2017 The Author
This is an open access article under the CC BY license (http://creativedetermine the transcriptional status of genes (Allis and Jenu-
wein, 2016). Importantly, sirtuins also deacetylate many non-
histone proteins, such as transcription factors and metabolic
enzymes, and can thus exert a profound effect on cellular
physiology.
Because sirtuins are dependent on NAD+, it is possible that
cellular processes modulated by sirtuins, including aging, are
influenced by changes in cellular NAD+ levels. We, and others
(Smith et al., 2000; Lin and Guarente, 2003), have shown that
mutations in or loss of NPT1 in NAD+ biosynthetic pathways
reduce NAD+ concentrations, resulting in a loss of silencing at
telomeres and rDNA, as well as significantly decreasing life-
span. Importantly, NAD+ levels decline in humans and other or-
ganisms as they age (Massudi et al., 2012; Braidy et al., 2011),
reducing the activity of SIRT1 and, likely, all seven mammalian
sirtuins. Since loss of sirtuins has been implicated in acceler-
ated aging (Ghosh and Zhou, 2015) and age-related diseases
(Bonkowski and Sinclair, 2016), we hypothesized that, if sirtuins
could function in the NAD+-depleted environment of aging, the
health benefits of these enzymes could be restored. Our
approach was to use mutagenesis and a genetic screen to iden-
tify mutations that allow yeast Sir2 function to persist in a low-
NAD+ setting. We identified two mutations in SIR2 that extend
replicative lifespan (RLS) and increase enzymatic activity in
low NAD+. The mutations appear to cause conformational
changes that improve the catalytic efficiency of Sir2, and this
effect is conserved when the mutations are installed in the
conserved, analogous residue in human SIRT1. Our experi-
mentally derived data are augmented by predictive protein
modeling, which supports our hypothesis that these mutations
increase the rigidity of the catalytic core and stabilize the mutant
enzymes. Our findings may thus identify a structural target for
a class of SIRT1-activating compounds that allow activity to
persist at low NAD+ levels.RESULTS
Strains Used to Select Sir2 Mutants
The main pathways involved in NAD+ biosynthesis in yeast and
other organisms are de novo synthesis of NAD+ from tryptophan
(requiring Qpt1) and the salvage pathway generating NAD+ from
nicotinamide (requiring Pnc1) and nicotinic acid (requiring Npt1)
(Bedalov et al., 2003; Lin and Guarente, 2003; Revollo et al.,s.
commons.org/licenses/by/4.0/).
Figure 1. Lifespan and Sirtuin Activity Are
Affected by NAD+ Loss, and Specific Sirtuin
Mutants Restore Activity in npt1D Mutants
(A) NAD+ levels are significantly decreased in the
npt1D yeast. Experiments were performed in dupli-
cate. Differences between means are statistically
significant (p < 0.0001).
(B)Survivalof rDNA::ADE2and tel::ADE2yeast strains
in NAD+-sufficient and limited backgrounds (npt1D).
Median NAD+-deficient lifespan for rDNA::ADE2 = 19
generations; sufficient NAD+ lifespan = 26; median
NAD+-deficient lifespan for tel::ADE2 = 19; sufficient
NAD+ lifespan = 30.5 (25–30 mother cells per strain).
Significance between NAD+-sufficient and -insuffi-
cient yeast strains (p < 0.0001)were determined using
the log-rank (Mantel-Cox) test.
(C and D) SIR2 activity assessed by chromatin
silencing of integrated ADE2 marker in WT, SIR2,
NPT1, and sir2D npt1D-deficient yeast—(C) tel::
ADE2 and (D) rDNA::ADE2. 1. WT yeast. 2. sir2D,
SIR2-deficient yeast 3. npt1D, NPT1-deficient
yeast 4. sir2D npt1D, SIR2 NPT1-deficient yeast;
rescue deletion strains with plasmids carrying SIR2
or NPT1. 5. sir2 + pRS316-SIR2. 6. npt1+ pRS316-
NPT1. 7. sir2D npt1D + pRS316-NPT1. 8. sir2D
npt1D + pRS316-SIR2. Note the sir2D npt1Dmutant
is not rescued to red by pRS316-SIR2.
(E and F) sir2D npt1D-deficient yeast—(E) tel::ADE2
and (F) rDNA::ADE2—transformed with WT SIR2
and mutant (E) K475E or (F) K475Q SIR2 plasmids.
WT SIR2-transformed strains (1 and 2) remain white,
indicating loss of silencing and Sir2 activity. K475E
or K475Q SIR2-transformed strains (3 and 4) result
in red colonies, indicating silencing of ADE2 and
active Sir2 in NAD+-deficient yeast.
(G) Multiple protein sequence alignment of se-
quences within the Rossman fold of sirtuin proteins
using COBALT. Lys residues at conserved site
(K475 in S. cerevisiae Sir2) are indicated in
red; C. elegans (Sir-2.1), M. musculus (SIRT1), and
H. sapiens (SIRT1).
(H and I) Protein blots of integrated Sir2 yeast.
(H, top) Western blot of Sir2 proteins isolated from
sir2D npt1D deletion strain, rDNA::ADE2. (I, bottom)
Western blot of Sir2 proteins isolated from sir2D
deletion strain, rDNA::ADE2. a-Tubulin loading
control was used. Survival of Sir2 WT and K475E,
K475Q mutants: (H) sir2D npt1D background
(NAD+-insufficient tel::ADE2, rDNA::ADE2); (I) sir2D
background (NAD+-sufficient tel::ADE2, rDNA::
ADE2). Figures represent data from a single,
representative experiment.
(J) Median survival of NAD+-insufficient (npt1D) and NAD+-sufficient yeast with integrated K475, K475E, or K475Q SIR2. Median lifespan was determined using
GraphPad Prism, and survival curves were determined to be significantly different between WT and mutant sirtuin enzymes using the log-rank (Mantel-Cox) test.2004). In our initial attempts to produce yeast with low enough
levels of NAD+ to inhibit Sir2 activity, we knocked out either
QPT1 or NPT1. Only knockout of NPT1 reduced NAD+ levels
enough to affect activity, consistent with earlier studies. This
strain also contained deletions of the SIR2 and ADE2 genomic
loci and had an integrated copy of ADE2 at either the rDNA or
the telomeres (both locations work comparably). When trans-
formed with a single copy of an ARS-CEN plasmid expressing
SIR2, red colonies form due to silencing of ADE2, while vector
control colonies not expressing Sir2 are white.NAD+ levels were decreased in npt1D yeast 3- to 4-fold, re-
sulting in a significant decrease in lifespan (Figures 1A and 1B).
We next assessed Sir2 activity by silencing the integrated
ADE2 marker at the telomeres and rDNA. Wild-type (WT) yeast
expressing Sir2 resulted in normal silencing, indicated pheno-
typically by red colonies (Figures 1C1 and 1D1), while yeast lack-
ing SIR2 (sir2D) were unable to silence ADE2 at either telomeres
or rDNA, resulting in white colonies (Figures 1C2 and 1D2). Yeast
lacking NPT1 (npt1D) resulted in white colonies, as NAD+ levels
were too low for Sir2 to function (Figures 1C3 and 1D3), and, asCell Reports 18, 2310–2319, March 7, 2017 2311
expected, double-knockout yeast lacking SIR2 and NPT1 (sir2D
npt1D) resulted in white colonies (Figures 1C4 and 1D4). We
were able to rescue the single mutants with plasmids expressing
SIR2 orNPT1 (Figures 1C5, 1C6, 1D5, and 1D6), thus resulting in
red colonies. Double-knockout strains (sir2D npt1D) were not
rescued with plasmids expressing either SIR2 or NPT1, resulting
in white colonies (Figures 1C7, 1C8, 1D7, and 1D8). These re-
sults indicate that a threshold level of NAD+ is required for Sir2
to function in yeast. We used our double-knockout strain (sir2D
npt1D) to select for sirtuin mutants capable of functioning in
NAD+-depleted cells.
Identification of Sir2 Mutants that Remain Active in an
NAD+-Deficient Environment
To test whether sirtuin activity could evolve to persist in low
NAD+ concentrations, we screened for mutations in the SIR2
gene that potentiate function of the sirtuin in the npt1D strain.
The SIR2 gene was mutagenized along its entire conserved
domain (residues 157–546) by error-prone PCR. Conditions
were experimentally derived to generate approximately one to
two mutations per gene and to reduce mutational bias, as moni-
tored by DNA sequencing of individual clones after mutagenesis.
When the mutagenized SIR2 plasmid was introduced into sir2D
npt1D double-mutant strains with ADE2 at the rDNA or telo-
meres, red colonies appeared rarely; of 30,000 colonies
screened, six mutants were identified. The isolated plasmids re-
transformed the sir2D npt1D mutants to produce red colonies.
The six SIR2 genes were sequenced, and every mutant con-
tained a change of Lys (K) 475 to either glutamic acid (Glu, E)
or glutamine (Gln, Q). In four mutants, additional single-point mu-
tations were present, but in two cases, the K475E and K475Q
represented single-amino-acid (AA) changes, indicating that
they conferred the phenotype. In Figures 1E and 1F, we show
the two yeast tester strains with ADE2 at rDNA and telomeres
lacking sir2D npt1D now transformed with WT, K475E (Fig-
ure 1E), and K475Q (Figure 1F) SIR2 plasmids. WT SIR2 trans-
formed colonies were white (Figures 1E and 1F), indicating loss
of silencing and Sir2 activity. K475E and K475Q SIR2 trans-
formed colonies were red (Figures 1E and 1F), indicating
silencing of ADE2 and active Sir2 in NAD+-deficient cells.
Importantly, K475 lies in the Rossmann fold of the NAD+-bind-
ing domain of sirtuins, and the known sirtuin structures indicate
that this Lys is in proximity to the NAD+-and substrate-binding
clefts (Min et al., 2001). This residue is conserved in Sir2 ortho-
logs among many species, including yeast, worm, mouse, and
human (Figure 1G). However, comparing sequences of the yeast
Sir2 and seven human sirtuin paralogs (Figure S1) revealed
that, although K475 is conserved in SIRT1 (K444) and SIRT7
(K272), the other five sirtuins contain either Glu (SIRT3 E323),
Gln (SIRT2 Q228; SIRT4 Q264, SIRT6 Q218), or valine (SIRT5
V253). Notably, SIRT5 is a desuccinylase and not a deacetylase
(Park et al., 2013). That six of the seven mammalian sirtuins
contain K, E, or Q at this site was intriguing, as these AAs
possess different physiochemical properties (+, , polar un-
charged), raising the possibility that this position might play
a direct role in catalysis or may alter interactions with surround-
ing residues to influence catalytic differences among sirtuin
paralogs.2312 Cell Reports 18, 2310–2319, March 7, 2017Mutant Sir2 Extends Lifespan in Both NAD+-Insufficient
and NAD+-Sufficient Yeast
We next determined the RLS of yeast with the K475E or K475Q
mutations integrated using pRS306 plasmids. We verified
protein expression and determined that levels of WT and mutant
proteins were similar in both NAD+-deficient (Figure 1H, top) and
NAD+-sufficient (Figure 1I, bottom) conditions. In both NAD+-
deficient (Figure 1H) and NAD+-sufficient (Figure 1I) strains, the
K475 mutations significantly extended lifespan compared to
WT SIR2: both Figures 1H and 1I show representative lifespan
curves; one from each reporter strain used in this study but
combining at least three independent experiments with 20–50
yeast cells each. Both median and maximal lifespans signifi-
cantly increased (p < 0.05) with the mutant enzymes (Figure 1J;
Supplemental Experimental Procedures).
Kinetic Analyses of Yeast Mutant Enzymes
To explain how these mutations confer both enhanced survival
and increased silencing activity, we characterized the sirtuin
mutants biochemically. We expressed 90% pure His-tagged
fusion WT and mutant Sir2 proteins (concentration verified by
Coomassie staining on an SDS-PAGE protein gel) (Figure 2A).
The deacetylation rate (concentration of deacetylated product
produced over time; Figure S2) was determined for WT and
mutant Sir2 proteins at saturating peptide (200 mM) or NAD+
(1 mM) concentrations against increasing concentrations of
NAD+ (0, 0.01, 0.02, 0.05, 0.1, 0.25, 0.5, and 1.0 mM) or peptide
(0, 0.05, 0.1, 0.25, 0.5, and 1.0 mM). Steady-state parameters
(Michaelis-Menten constant, KM; catalytic rate constant, kcat)
and catalytic efficiency (kcat/KM) were obtained using nonlinear
regression of the Michaelis-Menten equation (Figures 2B and
2C); values obtained from two independent replicates are indi-
cated by red (WT K475), teal (K475Q), and blue (K475E) circles.
Experimentally derived kinetic analyses are described in Fig-
ure 2G and in the Supplemental Experimental Procedures. Over-
all, the turnover of the mutant enzymes was improved (increased
kcat), and KM values for peptide (K475E) and NAD
+ (K475Q) were
lowered, which may also contribute to increased activity in vivo.
While our initial hypothesis was that the K475 mutant enzymes
would function by lowering KM values for NAD
+, ourmost consis-
tent finding is an overall increase in catalytic efficiency, which
may be driving the persistence of their activities in low NAD+
environments.
Kinetic Analyses of Human Mutant Enzymes
To determine whether these effects were limited only to yeast
Sir2 or whether they extend to other species, we expressed
WT SIRT1 K444 and the K444E (K444 corresponds to K475 in
Sir2) mutant as His-tagged fusion proteins. We focused exclu-
sively on the K444E mutant in SIRT1 protein, as this mutation
conferred the greatest effect in Sir2 protein. We followed similar
extraction and purification methods as with the yeast proteins to
yield 90% pure proteins (Figure 2D).
The steady-state parameters (KM and kcat) and catalytic effi-
ciency (kcat/KM) were determined using the Fluor-de-Lys (FDL)
SIRT1 Assay, which measures deacetylation of an acetyl-Lys
substrate (FDL) comprising AAs 379–382 of human p53
(RHKK(Ac)). We determined the velocities of the WT and mutant
Figure 2. Kinetic Parameters for Deacetylation by WT and Mutant Yeast and Human Enzymes
(A) Coomassie-stained protein gel of purified Sir2 proteins for kinetic analyses. Blot shows >90%pure proteins and densitometric analysis guided use ofmatched
protein concentrations for kinetic analyses.
(B and C) Enzymatic activity of WT and mutant sirtuins measured by deacetylation of 11-mer peptide H3K14ac in saturating NAD+ (or peptide) at varying NAD+
concentrations (B) or varying peptide concentrations (C) at multiple time points and fit to the Michaelis-Menten equation.
(D) Protein gel of purified human proteins for assay-based kinetic analyses, as for (A).
(E and F) Enzymatic activity of WT and mutant sirtuins measured by deacetylation of FDL substrate in saturating peptide with varying concentrations of NAD+ (E)
or saturating NAD+ and varying peptide (F). Deacetylation reactions were fit to the Michaelis-Menten equation.
(G) Yeast Sir2 and human SIRT1 deacetylation kinetics. Top: kcat and KM values were determined for Sir2 K475 and mutants Sir2 K475E or K475Q. Bottom: kcat
and KM values were determined for SIRT1 K444 and mutants SIR2 K444E using the FDL SIRT1 Assay. Calculated parameters were determined from nonlinear
regression fits to the Michaelis-Menten equation v = [(kcat/Km)(S)]/[1 + (S)/Km] (nR 2; data indicate mean ± SD).enzyme catalyzed reactions with increasing concentrations of
FDL substrate (0, 0.01, 0.02, 0.05, 0.1, 0.25, 0.5, and 1.0 mM)
and saturating concentrations of NAD+ (3.0 mM), as well as
with increasing concentrations of NAD+ (0, 0.01, 0.05, 0.1,
0.25, 0.5, 1.0, 2.5, and 5.0 mM) and saturating concentrations
of FDL substrate (1.0 mM). Multiple independent reactions
were performed. Representative sets of kinetic data for the
SIRT1 K444 and SIRT1 K444E catalyzed reactions are shown
in Figures 2E and 2F. Significant differences in the Vmax between
WT and mutant enzymes were apparent, and the experimentallyderived kinetic analyses are described (Figure 2G, bottom; Sup-
plemental Experimental Procedures). Our results indicate that
K444E SIRT1 is catalytically more active than WT (higher kcat)
and has a significantly lower KM for both substrates. Thus, it ap-
pears that enhanced catalytic efficiency is the conserved effect
of the K-to-E mutation in yeast Sir2 and mammalian SIRT1.
Additional kinetic analyses were performed using the SIRTainty
Assay to corroborate the FDL Assay. Representative data
from K444 and K444E catalyzed reactions performed with the
SIRTainty Assay are shown in Figure S3. Results show increasedCell Reports 18, 2310–2319, March 7, 2017 2313
catalytic efficiency by the K444E enzyme, corroborating results
from the FDL SIRT1 Assay.
We next examined the effect of themutations on the actions of
three compounds, the activator resveratrol and inhibitors sura-
min and nicotinamide. The NAD+ binding pocket of sirtuins is
divided into three regions (Min et al., 2001): the adenine ribose
of NAD+ binds the A site; nicotinamide ribose binds B; and the
reaction product nicotinamide binds C (Avalos et al., 2005). Sur-
amin bindswithin the B andCpockets, inhibiting sirtuin reactions
by blocking NAD+ access to the catalytic domain. Using the FDL
SIRT1 Assay, we inhibited the sirtuin reaction using a range of
suramin (0–1,000 mM). Results showed IC50 (half maximal inhib-
itory concentration) values of 2.99 mM for K444 and 68.02 mM for
K444E (Figure S4A), indicating that mutant K444E is much more
resistant to inhibition by suramin.We next determined the effects
of nicotinamide on WT and mutant SIRT1 and found IC50 values
of 43.05 mM for K444 and 34.27 mM for K444E (Figure S4B), indi-
cating, at best, a slight increase of inhibition of mutant SIRT1 by
nicotinamide. We also assessed the effects of resveratrol on the
mammalian K444Emutant. The activation peak was shifted from
1 mM to 10 mM in the mutant. Further, the K444E mutant could
not be activated by resveratrol to the degree of WT SIRT1 (Fig-
ure S4C). In a recent paper, the structure of SIRT1 in complex
with resveratrol and a 7-amino-4-methylcoumarin-containing
peptide showed binding of a resveratrol trimer in three different
conformations, one of which directly interacts with K444 (Cao
et al., 2015). We hypothesize that the K444E mutation disrupts
this interaction, thus explaining the decreased binding and
activation by resveratrol.
Mutant SIRT1 Enzymes Result in Decreased Acetylation
of In Vivo SIRT1 Substrates
After determining the catalytic differences of both yeast and hu-
man mutant proteins in vitro, we wanted to know whether these
mutations extended their effects to organisms beside yeast. To
determine how mutant human SIRT1 would affect downstream
targets in an in vivo cell-culture model, we evaluated differences
in sirtuin activity by measuring the steady-state acetylation
status of in vivo substrates. We thus performed transient
transfections of HEK293T cells with SIRT1 K444, K444E, and
K444Q plasmids. Transfecting 1 mg of each plasmid resulted
in increased SIRT1 protein expression relative to endogenous
protein expression (Figure 3A). A pan-acetyl-Lys blot of total
protein revealed that cells transiently transfected with K444E
or K444Q appeared to have less acetylation than K444 of
multiple cellular proteins, most notably, those in the 10- to
20-kDa range, where histone proteins run on 4%–15% SDS-
PAGE gels. It is known that in vivo recruitment of SIRT1 to
target promoters leads to gene silencing through histone de-
acetylation (Vaquero et al., 2007), particularly at H4K16 and
H3K9. We specifically probed for levels of H4K16ac and
found decreased acetylation by the K444E mutant (Figure 3B),
indicating that specific human substrates can be differentially
deacetylated by mutant sirtuins.
Next, we used SIRT1 null mouse embryonic fibroblasts
(MEFs) to produce stable cell lines expressing K444, K444E,
or K444Q. Figure 3C shows representative blots of two inde-
pendent sets of cell lines, illustrating a significant reduction in2314 Cell Reports 18, 2310–2319, March 7, 2017the acetylation of H4K16ac in cells expressing SIRT1 K444E
and, to a slightly lesser extent, K444Q. We observed higher
levels of the mutant SIRT1 proteins in these stable lines. To
determine whether this was due to differences in gene expres-
sion, we performed real-time qPCR and found that all three sta-
ble cell lines expressed similar levels of SIRT1 RNA (Figure 3D;
Table S1). This finding suggested that the mutant proteins
might be more stable than WT, as we address in the following
text, and indicates that the increased deacetylation of H4K16
by SIRT1 mutants may be due to higher catalytic activity plus
increased protein levels.
Predictive Protein Modeling Suggests Enhanced
Structural Stability of Mutant Sirtuin Proteins
To gain mechanistic insight into how the mutations might result
in more catalytically active enzymes and whether the stability
of the protein could be altered due to the mutations, we used
predictive protein modeling to examine how these single-
AA changes may affect enzyme stability and function. The
conserved domain sequence (residues 231–555) of Sir2 was
submitted to the ENCoMweb server (Frappier and Najmanovich,
2015; Supplemental Experimental Procedures), and DDG values
were calculated for WT and compared to K475 mutant enzymes,
with negative DDG values indicating increased thermodynamic
structural rigidity. Strikingly, both K475E and K475Q mutations
increased rigidity across the entire domain of residues 231–
555 in a rank order that follows their increased kcat values (Fig-
ure 4A). Next, we used ENCoM to calculate how each K475 mu-
tation affected the rigidity at each residue of the 231–555 domain
compared to WT, using the area under the curve (AUC) of
receiver operator curves (ROCs). AUCs were distributed from
0.00 to 0.5 (blue to red), where AUC = 0 corresponds to cases
where the mutants had the most pronounced rigidifying effect
(blue) and AUC = 0.5 represents cases where the mutants
have an average effect (red) (Figure 4B). This analysis reveals re-
gions of increased rigidity by both mutants, compared toWT en-
compassing two main regions, A and B (B includes K475 itself).
These regions are mapped onto the Sir2 structure, indicating
the average effect of both K475E and K475Q mutations and
reveal a close proximity of K475 in region B and R275 in region
A (Figure 4C, region A indicated in blue and region B indicated
in teal). The structure, indeed, predicts that K475 and R275
exhibit a repulsive charge interaction (Figure 4D). Moreover, we
hypothesize that in the K475 mutants, attractive charge-charge
(K475E) or hydrogen bonding (K475Q) can now occur, which
may increase the catalytic cleft stability (Figure 4D). Notably,
R275 is at the acetyl-Lys binding cleft and is highly conserved
in SIR2 orthologs.
Since K475 and R275 are highly conserved residues, and it
is well established that conserved residues are often crucial for
protein function, we examined the conservation level of 150 sir-
tuin and sirtuin-related sequences using ConSurf (Ashkenazy
et al., 2016). Residues forming the NAD+ and protein sub-
strate-binding pocket were identified by contact greater than
10 A˚, using a Voronoi surface algorithm between the ligand
and residues within the crystal structure (McConkey et al.,
2002). Blue residues indicate high conservation, and red resi-
dues indicate no conservation among species (Figure 4E).
Figure 3. SIRT1 Expression and Activity
In Vivo
(A and B) Cell lysates prepared from 293T cells
transfected with SIRT1 K444, K444E, and K444Q
plasmids. Protein blots probed for hSIRT1, pan-
acetyl Lys, and a-tubulin (A) and for total histone 4
(H4) and H4K16Ac (B). Quantification of SIRT1 pro-
tein expression was performed using ImageJ, rela-
tive to a-tubulin and normalized to 1. Quantification
of H4K16ac relative to total H4 was performed using
ImageJ and normalized to 1.
(C) Cell lysates prepared from SIRT1 null MEFs
stably transfected with K444, K444E, and K444Q
SIRT1 lentiviral expression vectors (two indepen-
dent viral infections). Protein blots probed for SIRT1,
H4K16ac, H4, and a-tubulin. Quantification was
performed using ImageJ and normalized: SIRT1
levels relative to a-tubulin and H4K16ac levels rela-
tive to H4. Mutant protein expression levels are
relative to WT expression that is normalized to 1.
SDs indicate differences between stable lines.
(D) Scatterplots of qRT-PCR data of SIRT1 mRNA
expression in WT MEFs, SIRT1 null MEFs, and sta-
ble MEF cells expressing SIRT1 WT, K444E, or
K444Q. SIRT1 expression is relative to GAPDH and
actin mRNA and normalized to WT MEF levels of
SIRT1. A one-way ANOVA statistical test was used
with Dunnett’s multiple comparisons test to detect
differences in cell types relative to the SIRT1 WT
condition. 95% confidence intervals are indicated.
Statistically significant differences (p < 0.05) are
indicated.
See also Table S1.Note that the most conserved regions in the AUC plot include re-
gions A and B of Figure 4B.
Next, we compared the stabilization effects of the K475 muta-
tions with all 6,156 possible AA substitutions across the 231–555
domain (324 residues multiplied by 19 AAs, minus STOP resi-
dues). We calculated a DDG score for each of the 6,156 muta-
tions versus WT and ranked their DDG effects at each residue
compared to the K475 mutations again using AUCs of the
ROC (Figure 4E). Blue indicates that the K475 mutants had the
most pronounced rigidifying effect compared to the 6,156
changes, and white indicates that the mutants had an average
effect compared to the other 6,156 mutants. The strongest rigid-
ifying effects of the K475 mutations compared to the other 6,156
possible changes, again, are in regions A and B. These same re-
gions are projected onto the structure (Figure 4F) distributed
from more rigid (blue) to less rigid (white) and correspond well
with a projection of the most highly conserved residues ontoCell Rthe structure (Figure 4G). This structural
analysis gives strong theoretical evidence
that the K475 mutations increase the
rigidity of the catalytic domain, possibly
by creating charge or ionic interactions
with R275, and that these changes in local
dynamic properties may contribute to
increased stability and increased catalytic
efficiency in mutant enzymes. This mightoccur, for example, by reducing the time the protein is in a
breathing (inactive) state.
Mutant Human SIRT1 Shows Increased Protein Stability
In Vivo and In Vitro
The findings of ENCoM analysis predict that the mutant SIRT1
proteins display increased stability in vivo. Therefore, we as-
sayed whether the higher levels of SIRT1 mutants were a result
of increased protein stability. Various studies have measured
SIRT1 half-life at between 4 and 12 hr (Gao et al., 2011; Ford
et al., 2008) after using cycloheximide (CHX) to inhibit protein
synthesis (Sto¨cklein and Piepersberg, 1980). SIRT1 null MEF
lines expressing K444, K444E, and K444Q SIRT1 were treated
with DMSO (solvent control) (Figure 5A) or CHX (Figure 5B),
and protein lysates were collected at 0, 1, 2, 4, 8, and 12 hr
post-treatment. Our results show that WT SIRT1 protein starts
declining at 4 hr, with a significant loss of protein expression ateports 18, 2310–2319, March 7, 2017 2315
Figure 4. Effect of Mutations on Sirtuin Rigidity and Predictive Modeling of Sir2 Structure
(A) Graph of calculated DDG (difference in Gibbs free energy between WT and mutant) for WT and mutant Sir2 protein residues 231–555 versus experimentally
derived kcat values (Figure 2). A strong correlation between DDG and kcat is evident.
(B) Heatmap of DDG values for each residue of mutant versus WT. Blue residues indicate negative DDG and increased rigidity in mutant, white residues indicate
no differences, and red residues indicate decreased rigidity. Two distinct regions, A and B, of residues positively affected by the K475 mutation are indicated.
Average trace indicates the calculated average DDG values as a result of K475E, K475Q mutations combined.
(C) Structure of Sir2 with regions A (blue) and B (teal). Note proximity of K475 and R275, within regions B and A, respectively.
(D) Schematic of Sir2 catalytic domain with putative chemical interactions between residues Ser473, Arg275, and Lys475 (left) or Glu475 (right).
(E) Top: AUC heatmap represents the residue-by-residue rigidity rank of the K475E, K475Q mutants versus all other possible AA substitutions (6156) in the 231–
555 domain (blue, more rigid; white, less rigid). Bottom: conservation heatmap represents the conservation among sirtuin sequences analyzed using ConSurf
(blue, high conservation; red, no conservation).
(F) AUC, from (E), projected onto Sir2.
(G) Conservation map, from (E), projected onto Sir2. Note the large overlap between (F) and (G), notably within regions A and B.8 and 12 hr post-treatment (Figure 5B). In contrast, both mutant
SIRT1 proteins only start to decline at 8 hr; remaining >3-fold
higher at 8 and 12 hr than WT protein (Figures 5C and 5D). We
also performed thermal shift assays of purified WT and mutant
Sir2 proteins to determine the melting temperature (Tm) and,
thus, the stability of the enzymes. We determined that the Tm
increased in a rank order, with highest average Tms of 48.4
C
for K475 Sir2, 50.9C for K475Q, and 52.8C for K475E (Figures
S5A and S5B). Thus, both mutant proteins demonstrate evi-2316 Cell Reports 18, 2310–2319, March 7, 2017dence of increased thermostability in vitro and are also signifi-
cantly more stable in cells than WT protein.
DISCUSSION
In this study, we used a genetic screen to produce sirtuins
capable of functioning in an NAD+-depleted environment. Sir-
tuins share a highly conserved catalytic domain consisting of
distinct sites that bind NAD+ and protein substrates and are
Figure 5. In Vivo Effect of Human SIRT1Muta-
tions on Protein Expression and Stability
(A and B) SIRT1 null MEFs stably transfected
with K444, K444E, and K444Q SIRT1 lentiviral
expression vectors. Cells were treated with DMSO
(one experiment) (A) or CHX (representative of
three independent experiments shown) (B) for
increasing time lengths. Loss of SIRT1 protein
expression was evaluated via western blotting and
densitometry.
(C) Optical density of SIRT1 protein, quantified
using ImageJ and normalized to b-actin, and pro-
tein expression levels at time (t) = 0 (relative to 1)
were plotted. Data represent the mean ± SD of
three independent experiments. Lines were drawn
using linear regression of datasets using GraphPad
Prism.
(D) Data at 8 and 12 hr post-CHX treatment, indi-
cating significant (p < 0.001) differences between
mutant and WT proteins (two-way ANOVA, Dun-
nett’s multiple comparisons test) (K444 versus
K444E, p = 0.0004; K444 versus K444Q, p = 0.0002).sensitive to cellular NAD+ levels. As NAD+ levels decrease with
age, NAD+-dependent sirtuins decrease in activity. We thus
genetically engineered yeast to have a 3- to 4-fold reduction in
NAD+ levels, which was sufficient to abolish the red colony color
due to Sir2-mediated silencing of an ADE2 gene. After mutagen-
esis across the conserved domain of SIR2, we screened for red
transformants and identified two adaptive mutations in residue
K475, which restored Sir2 activity in an NAD+-limited environ-
ment and extended yeast RLS. The in vitro kinetics analyses indi-
cated modestly decreased KM for NAD
+ by the K475Q mutant
and for peptide by the K475Emutant. However, themost consis-
tent effect observed in the mutant sirtuins was a 2- to 3-fold
increase in kcat, indicating a significant increase in catalytic
efficiency.
Importantly, K475 is conserved in all Sir2 orthologs. Replacing
K444 (analogous to Sir2 K475) of human SIRT1 with E also
increased the kcat of the human enzyme, while lowering the KM
for both substrates. Moreover, the K444E and K444Q mutants
gave rise to a higher degree of deacetylation in human and mu-
rine cells than WT. In particular, histone H4K16, a known sub-
strate for Sir2 orthologs, wasmore deacetylated in cells express-
ing the mutants. These findings indicate a striking functional
conservation in this catalytically placed Sir2 Lys and show that
the increase in catalytic efficiency conferred by this mutation
extends to mammalian SIRT1.
To gain mechanistic insight into how our mutations result
in more catalytically efficient enzymes, we looked into the
structural changes that might occur using predictive protein
modeling. The dynamic regulation of biochemical processes in
the cell involves entropic effects and molecular forces between
interacting groups, such as between sirtuins and their substrates
(Leckband and Israelachvili, 2001). The analysis of our mutants
predicts a decreased DDG, suggesting increased rigidity of the
catalytic core. This analysis also suggests that the Lysmutations
may exert their effects by introducing a favorable interaction witha conserved Arg (R275 in Sir2). Increased catalytic site rigidity
can enhance stability and catalysis of some enzymes (Xie
et al., 2014). Consistent with the predicted increase in stability,
we demonstrated increased melting temperatures of mutant
Sir2 enzymes in vitro and increased half-lives of mutant human
sirtuins in cultured mammalian cells compared to WT protein.
There are examples of improved enzymes produced using
methods similar to ours, such as LovD, a natural enzyme that
was transformed, using a genetic screen (Jime´nez-Ose´s et al.,
2014), into a variant 1,000-fold more efficient at synthesizing
the drug simvastatin than WT LovD. This variant achieved
enhanced catalysis as measured by a significant increase of
kcat, not through significant changes of binding affinity (KM).
The mutations altered the conformational dynamics of the en-
zyme’s catalytic domain, leading to enhanced rigidity and higher
thermostability. Notably, whereas our mutant sirtuins contain
only one mutated residue and increased catalytic efficiency by
2- to 3-fold, mutant LovD alters 29 residues. It is plausible that
sirtuin enzymes can be optimized further by including changes
predicted by our modeling.
While our nicotinamide inhibition does not show significant
differences between WT or mutant enzymes, we do demon-
strate differential effects of mutant sirtuins compared to WT in
response to resveratrol and suramin. For suramin, a large in-
crease in the inhibitor constant Ki was observed, which may
be due to the predicted higher rigidity of the catalytic core.
For example, if breathing of this structure is required for sura-
min to bind, a lower affinity might be expected for the mutants.
Of course, a more rigid catalytic domain could also inhibit the
binding of certain Sir2 substrates, which require breathing of
the catalytic core. In this regard, it will be of interest to examine
the effects of SIRT1 K444E and K444Q mutations on many
cellular substrates by a proteomics approach. For resveratrol,
there appeared to be both an increase in Km and a decrease
of maximal activation. Both may be due to the fact thatCell Reports 18, 2310–2319, March 7, 2017 2317
structural studies show that resveratrol contacts K444 (Cao
et al., 2015).
In yeast, integrated copies of the mutant SIR2 genes gave rise
to increased silencing compared to WT. In this case, the expres-
sion levels of all proteins were indistinguishable, so we attribute
the hypermorphic phenotype of the mutants to their altered cat-
alytic properties. In mammalian cells, however, stable lines
showed slightly higher levels of mutant proteins compared to
WT. Therefore, we cannot be certain whether the increase in de-
acetylation observed in mammalian cells expressing SIRT1 mu-
tants is driven by higher catalytic activity, higher protein levels, or
both. The higher protein levels are consistent with the mutations
conferring a higher intrinsic stability. Differences in the protein
turnover machinery or negative-feedback regulation (Michel
et al., 2005) are possible explanations for why higher mutant pro-
tein levels were not observed in yeast.
The conserved effect of the mutations suggests a possible
strategy for increasing SIRT1 activity separate from the use of
conventional SIRT1-activating compounds. These compounds,
including polyphenols like resveratrol and additional compounds
under development at GSK (GlaxoSmithKline), work by lowering
the KM of the enzyme for the protein substrate. We imagine that
an assay similar to ours could screen for small molecules that
activate yeast Sir2 in low NAD+ cells to reveal lead compounds
that function like our Lys mutations and increase the catalytic ef-
ficiency of the enzyme. Such molecules may provide another
translational path for activating SIRT1. Moreover, they may
also activate SIRT7, which also has a Lys at the analogous posi-
tion as K444 in SIRT1, and thereby exert a unique effect on cells.
In summary, we discovered that mutations in the previously
uninvestigated residue, K475, to E or Q result in catalytically
improved enzymes. This Lys is conserved in all Sir2 orthologs,
and these mutations exert similar effects on the human enzyme.
Computational and experimental methods suggest that the mu-
tations increase the stability of two regions in the catalytic core of
the enzyme. We hypothesize that, by increasing the rigidity, and
thus the stability, of the catalytic domain, the K475E and K475Q
enzymes breathe less and are locked into an active state, allow-
ing faster deacetylation. Since the mutant Sir2 orthologs might
function in the NAD+-depleted setting of aging, our findings
may potentiate a strategy for treating diseases of aging.
EXPERIMENTAL PROCEDURES
NAD+ Quantification
NAD+ quantification was performed using the NAD/NADH Assay (Promega),
following the manufacturer’s protocol and yeast-specific methods. NAD+
levels are indicated in relative light units (RLUS), relative to total protein
expression.
Yeast RLS Analysis
Micromanipulation and RLS analysis of yeast were performed with 20–50
mother cells per experiment and carried out at least three times.
Sir2 Deacetylation Assay
Deacetylation of a synthetic 11-mer peptide corresponding to Lys 14 of
histone H3 plus surrounding residues by WT and mutant Sir2 was measured.
Reaction productswere separated by HPLC on a Kinetex XB-C18 column, and
product conversion was determined by comparing the ratio of deacetylated to
acetylated peptide substrate.2318 Cell Reports 18, 2310–2319, March 7, 2017SIRT1 Activity: FDL Assay
The steady-state parameters (Km and kcat) and catalytic efficiency (kcat/Km) of
recombinant human SIRT1 were determined using the FDL SIRT1 Fluoro-
metric Assay. All rate measurements were obtained from three or more repli-
cates and performed independently at least two times.
RNA Extraction and Real-Time qPCR
Total RNA was extracted from cells by the RNeasy Mini Kit. cDNA was synthe-
sized using the RETROscript kit. All PCR reactions were performed in triplicate
with SYBR Green in a Light Cycler 480. Relative RNA expression levels were
estimated using the DDCTmethod, with normalization to GAPDH and b-actin.
Inhibition of De Novo Protein Synthesis
MEFs were treated with 150 mg/mL CHX or DMSO. Total protein samples were
harvested, and protein concentration was verified using bicinchoninic acid
(BCA). Total protein was loaded on precast protein gels (Bio-Rad) and
analyzed via western blotting.
Statistical Methods
Graphs were made and statistical analyses were performed using GraphPad
Prism. Statistical analysis of yeast lifespan was determined using the log-
rank (Mantel-Cox) test. Kinetic analyses were performed using the Michae-
lis-Menten model. Statistical analysis for qRT-PCR was determined using
two-way ANOVA, with Dunnett’s multiple comparisons test. Inhibition studies
were analyzed using nonlinear exponential decay. Analyses of paired values of
data were performed with paired two-tailed t tests.
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